|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2007-2-15
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Treatment of acute Kawasaki disease with intravenous immune globulin and aspirin reduces the risk of coronary-artery abnormalities and systemic inflammation, but despite intravenous immune globulin therapy, coronary-artery abnormalities develop in some children. Studies have suggested that primary corticosteroid therapy might be beneficial and that adverse events are infrequent with short-term use.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
pubmed-author:AtzAndrew MAM,
pubmed-author:BakerAnnette LAL,
pubmed-author:ColanSteven DSD,
pubmed-author:GersonyWeltonW,
pubmed-author:KleinGloria LGL,
pubmed-author:LiJennifer SJS,
pubmed-author:McCrindleBrian WBW,
pubmed-author:MinichL LuAnnLL,
pubmed-author:MitchellPaul DPD,
pubmed-author:NewburgerJane WJW,
pubmed-author:Pediatric Heart Network Investigators,
pubmed-author:SleeperLynn ALA,
pubmed-author:SundelRobert PRP,
pubmed-author:TakahashiMasatoM,
pubmed-author:VetterVictoria LVL
|
|
pubmed:copyrightInfo |
Copyright 2007 Massachusetts Medical Society.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
356
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
663-75
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:17301297-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:17301297-Aspirin,
pubmed-meshheading:17301297-Child,
pubmed-meshheading:17301297-Child, Preschool,
pubmed-meshheading:17301297-Coronary Artery Disease,
pubmed-meshheading:17301297-Double-Blind Method,
pubmed-meshheading:17301297-Drug Therapy, Combination,
pubmed-meshheading:17301297-Female,
pubmed-meshheading:17301297-Fever,
pubmed-meshheading:17301297-Glucocorticoids,
pubmed-meshheading:17301297-Humans,
pubmed-meshheading:17301297-Immunoglobulins, Intravenous,
pubmed-meshheading:17301297-Immunologic Factors,
pubmed-meshheading:17301297-Infant,
pubmed-meshheading:17301297-Infusions, Intravenous,
pubmed-meshheading:17301297-Male,
pubmed-meshheading:17301297-Methylprednisolone,
pubmed-meshheading:17301297-Mucocutaneous Lymph Node Syndrome,
pubmed-meshheading:17301297-Pulse Therapy, Drug
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.
|
|
pubmed:affiliation |
Department of Cardiology, Children's Hospital and Harvard Medical School, Boston, MA 02115, USA. jane.newburger@cardio.chboston.org
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Research Support, N.I.H., Extramural
|
